Underwriting Agreement Sample Contracts

MR2 Group, Inc. – Mr2 Group, Inc. Underwriting Agreement (August 20th, 2018)
10,398,942 Shares GODADDY INC. CLASS a COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (August 17th, 2018)
Global Net Lease, Inc. – UNDERWRITING AGREEMENT 4,000,000 Shares of Common Stock (August 17th, 2018)

Global Net Lease, Inc., a Maryland corporation (the "Company"), and Global Net Lease Operating Partnership, L.P., a Delaware limited partnership (the "Operating Partnership"), jointly and severally, confirm their agreement with BMO Capital Markets Corp. and UBS Securities LLC, acting as representatives (the "Representatives") of the Underwriters named in Schedule I hereto (the "Underwriters"), with respect to the issue and sale by the Company and the purchase by the Underwriters subject to the terms and conditions stated in this agreement (this "Agreement"), of an aggregate of 4,000,000 shares (the "Firm Shares") of the Company's common stock, $0.01 par value per share (the "Common Stock"). The Company has also agreed to grant to the Underwriters an option to purchase up to an additional 600,000 shares of Common Stock (the "Option Shares"). The Firm Shares and the Option Shares are hereinafter collectively referred to as the "Shares."

South Carolina Electric & Gas Co – SOUTH CAROLINA ELECTRIC & GAS COMPANY $300,000,000 First Mortgage Bonds, 3.50% Series Due 2021 $400,000,000 First Mortgage Bonds, 4.25% Series Due 2028 UNDERWRITING AGREEMENT (August 16th, 2018)
Tenzing Acquisition Corp. – 5,000,000 Units Tenzing Acquisition Corp. UNDERWRITING AGREEMENT (August 16th, 2018)
YayYo, Inc. – Underwriting Agreement (August 16th, 2018)
Megalith Financial Acquisition Corp – 15,000,000 Units Megalith Financial Acquisition Corp. UNDERWRITING AGREEMENT (August 16th, 2018)
Gladstone Investment Corporation – GLADSTONE INVESTMENT CORPORATION Shares of Preferred Stock UNDERWRITING AGREEMENT (August 16th, 2018)
BioNano Genomics, Inc – BIONANO GENOMICS, INC. UNDERWRITING AGREEMENT [ ] Units (August 15th, 2018)
U.S. BANCORP UNDERWRITING AGREEMENT STANDARD PROVISIONS (PREFERRED STOCK, WHICH MAY BE REPRESENTED BY DEPOSITARY SHARES) (August 7, 2018) (August 14th, 2018)

This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

Underwriting Agreement (August 14th, 2018)

We (the Representatives) understand that U.S. Bancorp, a Delaware corporation (the Company), proposes to issue and sell to the several underwriters named in Schedule I (the Underwriters) an aggregate of 23,000,000 Depositary Shares (the Offered Securities and each a Offered Security), each representing 1/1000th of a share of the Companys Series K Non-Cumulative Perpetual Preferred Stock, $1.00 par value, with a liquidation preference of $25,000 per share (the Preferred Stock). The Preferred Stock, when issued, will be deposited against delivery of Depositary Receipts (the Depositary Receipts), which will evidence the Depositary Shares, that are to be issued by U.S. Bank National Association (the Depositary) under the Deposit Agreement, to be dated as of August 14, 2018, among the Company, the Depositary and the holders from time to time of the Depositary Receipts issued hereunder.

Ampio Pharmaceutical – AMPIO PHARMACEUTICALS, INC. (A Delaware Corporation) AMENDMENT NO. 1 TO UNDERWRITING AGREEMENT (August 13th, 2018)
Citius Pharmaceuticals, Inc. – Underwriting Agreement (August 13th, 2018)
Remora Royalties, Inc. – Remora Royalties, Inc. [*] Shares Class a Common Stock ($0.01 Par Value Per Share) Underwriting Agreement (August 13th, 2018)
Chase Bank Usa, National Association – CHASE ISSUANCE TRUST (Issuing Entity) CHASE BANK USA, NATIONAL ASSOCIATION (Sponsor, Servicer and Administrator) CHASE CARD FUNDING LLC (Depositor, Transferor and Beneficiary) UNDERWRITING AGREEMENT (Standard Terms) (August 10th, 2018)
9,090,909 Shares Progenics Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (August 10th, 2018)

Introductory. Progenics Pharmaceuticals, Inc., a Delaware corporation (the "Company"), proposes to issue and sell to the several underwriters named in Schedule A (the "Underwriters") an aggregate of 10,454,545 shares of its common stock, par value $0.0013 per share (the "Shares"). The 9,090,909 Shares to be sold by the Company are called the "Firm Shares." In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,363,636 Shares as provided in Section 2. The additional 1,363,636 Shares to be sold by the Company pursuant to such option are collectively called the "Optional Shares." The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the "Offered Shares." Jefferies LLC ("Jefferies") and Credit Suisse Securities (USA) LLC ("Credit Suisse") have agreed to act as representative of the several Underwriters (in such capacity, the "Representatives") in connection with the offering and sale of

Gores Holdings III, Inc. – 37,500,000 Units Gores Holdings III, Inc. UNDERWRITING AGREEMENT (August 10th, 2018)
Workhorse Group Inc. – Underwriting Agreement (August 9th, 2018)
Tottenham Acquisition I Ltd – 4,000,000 Units Tottenham Acquisition I Limited UNDERWRITING AGREEMENT (August 7th, 2018)
Underwriting Agreement (August 7th, 2018)
Citius Pharmaceuticals, Inc. – Underwriting Agreement (August 6th, 2018)
Four Corners Property Trust, Inc. – 3,500,000 Shares FOUR CORNERS PROPERTY TRUST, INC. Common Stock, Par Value $0.0001 Per Share UNDERWRITING AGREEMENT (August 6th, 2018)
TKK SYMPHONY ACQUISITION Corp – 20,000,000 Units TKK SYMPHONY ACQUISITION CORPORATION UNDERWRITING AGREEMENT (August 6th, 2018)
Tenzing Acquisition Corp. – 5,000,000 Units Tenzing Acquisition Corp. UNDERWRITING AGREEMENT (August 6th, 2018)
Underwriting Agreement (August 3rd, 2018)

Tandem Diabetes Care, Inc., a Delaware corporation (the "Company"), confirms its agreement with Oppenheimer & Co. Inc. ("Oppenheimer") and each of the other Underwriters named in Schedule A hereto (collectively, the "Underwriters," which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Oppenheimer is acting as representative (in such capacity, the "Representative"), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of Common Stock, par value $0.001 per share, of the Company ("Common Stock") set forth in Schedule A hereto and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 526,315 additional shares of Common Stock. The aforesaid 3,508,770 shares of Common Stock (the "Initial Securities") to be purchased by the Unde

Stv Group Inc – Underwriting Agreement (August 3rd, 2018)
Viper Energy Partners LP – VIPER ENERGY PARTNERS LP 9,000,000 Common Units Representing Limited Partner Interests UNDERWRITING AGREEMENT (August 3rd, 2018)
Bank 2018-Bnk13 – BANK 2018-Bnk13 COMMERCIAL MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2018-Bnk13 UNDERWRITING AGREEMENT as of July 23, 2018 (August 2nd, 2018)

Wells Fargo Commercial Mortgage Securities, Inc., a North Carolina corporation (the "Depositor"), intends to issue its BANK 2018-BNK13, Commercial Mortgage Pass-Through Certificates, Series 2018-BNK13 (the "Certificates"), in twenty-two (22) classes and interests (each, a "Class") as designated in the Prospectus (as defined below). Pursuant to this underwriting agreement (the "Agreement"), the Depositor further proposes to sell to Wells Fargo Securities, LLC ("Wells Fargo Securities"), Morgan Stanley & Co. LLC ("MS&Co."), Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPF&S"), Academy Securities, Inc. ("Academy") and Drexel Hamilton, LLC ("Drexel" and, collectively with Wells Fargo Securities, MS&Co., MLPF&S and Academy, the "Underwriters" and each, individually, an "Underwriter") the Certificates set forth in Schedule I hereto (the "Registered Certificates") in the respective original principal amounts and notional amounts set forth in Schedule I. The Certificates represent in

Airxpanders Inc – Underwriting Agreement (August 2nd, 2018)

Table of contents 1 Definitions and interpretation 2 1.1 Definitions 2 1.2 Interpretation 10 1.3 Business Days 11 1.4 Valid Application 12 1.5 Knowledge 12 2 Appointment 12 2.1 Appointment 12 2.2 Agreement to underwrite 12 2.3 Sub-underwriting 12 2.4 Co-lead managers, Co-managers and brokers 13 3 Conditions 13 3.1 Condition precedent to binding agreement 13 3.2 Conditional obligations of the Underwriter 13 3.3 Obligation to satisfy conditions 14 3.4 Waiver 14 3.5 Notice 14 3.6 Conditions not satisfied 14 4 R

GLOBAL PARTNERS LP 2,400,000 9.75% Series a Fixed-To-Floating Rate Cumulative Redeemable Perpetual Preferred Units Representing Limited Partner Interests UNDERWRITING AGREEMENT (August 2nd, 2018)

This is to confirm the agreement by and among the Partnership, Global GP LLC, a Delaware limited liability company (the General Partner), and Global Operating LLC, a Delaware limited liability company (Global Operating and, together with the Partnership and the General Partner, the Partnership Parties), on the one hand, and the Underwriters, on the other hand, concerning the purchase of the Units from the Partnership by the Underwriters. Global Companies LLC, a Delaware limited liability company (Global Companies), Global Montello Group Corp., a Delaware corporation (Global Montello), Global Partners Energy

BeiGene, Ltd. – HONG KONG UNDERWRITING AGREEMENT Relating to a Public Offering in Hong Kong of Initially 5,904,000 Shares of Nominal Value of US$0.0001 Per Share in the Capital of BeiGene, Ltd., Being Part of a Global Offering of Initially 65,600,000 Shares (August 1st, 2018)
Bancwest Corp – First Hawaiian, Inc. Common Stock, Par Value $0.01 Per Share Underwriting Agreement (August 1st, 2018)
Teladoc, Inc. – UNDERWRITING AGREEMENT TELADOC, INC. 5,263,740 Shares of Common Stock, Par Value $0.001 Per Share Underwriting Agreement (July 26th, 2018)

Teladoc, Inc., a Delaware corporation (the Company), proposes to issue and sell to Jefferies LLC (the Underwriter) and certain stockholders of the Company named in Schedule 2 hereto (the Selling Stockholders) severally, and not jointly, propose to sell to the Underwriter, an aggregate of 5,263,740 shares (the Underwritten Shares) of common stock, par value $0.001 per share, of the Company (the Common Stock), of which 5,000,000 shares are to be issued and sold by the Company and 263,740 shares are to be sold by the Selling Stockholders in the respective amounts set forth opposite their names in Schedule 2 hereto. In addition, the Selling Stockholders propose to sell, at the option of the Underwriter, up to an additional 750,000 shares of Common Stock (the Option Shares). The Underwritten Shares and the Option Shares are herein referred to as the Shares. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the Stock.

Class a Common Stock BEASLEY BROADCAST GROUP, INC. UNDERWRITING AGREEMENT (July 26th, 2018)
Dolphin Digital Media – 2,000,000 Shares of Common Stock of Dolphin Entertainment, Inc. Underwriting Agreement (July 24th, 2018)